These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Viral-specific humoral immune responses following transfusion-related transmission of human T cell lymphotropic virus type-I infection. Manns A; Wilks RJ; Hanchard B; Morgan OS; Rudolph DL; Lal RB Viral Immunol; 1994; 7(3):113-20. PubMed ID: 7598784 [TBL] [Abstract][Full Text] [Related]
6. [Difference of antibody profile for human T-lymphotropic virus type-I (HTLV-I) among individuals]. Kamihira S; Sohda H; Momita S; Amagasaki T; Yamada Y; Ikeda S; Tomonaga M; Ichimaru M; Kinosita K; Sawada T Rinsho Ketsueki; 1989 Jun; 30(6):823-9. PubMed ID: 2795893 [TBL] [Abstract][Full Text] [Related]
7. [Oligoclonal IgG bands in patients with HTLV-I associated myelopathy--detection by agarose isoelectric focusing, transfer to cellulose nitrate and immunoperoxidase staining]. Saito T; Osame M; Usuku K; Matsumoto M; Igata A Rinsho Shinkeigaku; 1989 Aug; 29(8):976-81. PubMed ID: 2689034 [TBL] [Abstract][Full Text] [Related]
8. Epitope analysis of the cerebrospinal fluid IgG in HTLV-I associated myelopathy patients using phage display method. Fujimori J; Nakashima I; Fujihara K; Feng J; Yamamoto M; Yamamoto N; Begum N; Sagara Y; Shiraki H; Shiga Y; Onodera J; Sato S; Takase S; Asano M; Endo M; Itoyama Y J Neuroimmunol; 2004 Jul; 152(1-2):140-6. PubMed ID: 15223246 [TBL] [Abstract][Full Text] [Related]
9. Neuronal molecular mimicry in immune-mediated neurologic disease. Levin MC; Krichavsky M; Berk J; Foley S; Rosenfeld M; Dalmau J; Chang G; Posner JB; Jacobson S Ann Neurol; 1998 Jul; 44(1):87-98. PubMed ID: 9667596 [TBL] [Abstract][Full Text] [Related]
11. [Human T-lymphotropic virus type I (HTLV-I): risk of transmission with transfusion]. Lefrère JJ Presse Med; 2000 Jun; 29(20):1134-8. PubMed ID: 10901796 [TBL] [Abstract][Full Text] [Related]
12. Human T-lymphotropic virus type-1 (HTLV-1) in Israeli patients and their family relatives and its transmission to rats. Shohat M; Shohat B; Achiron A Med Microbiol Immunol; 2006 Jun; 195(2):93-9. PubMed ID: 16220308 [TBL] [Abstract][Full Text] [Related]
13. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Burbelo PD; Meoli E; Leahy HP; Graham J; Yao K; Oh U; Janik JE; Mahieux R; Kashanchi F; Iadarola MJ; Jacobson S Retrovirology; 2008 Oct; 5():96. PubMed ID: 18937847 [TBL] [Abstract][Full Text] [Related]
17. Elimination of human T cell leukemia virus type-1-infected cells by neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies against human t cell leukemia virus type-1 envelope gp46. Tanaka Y; Takahashi Y; Tanaka R; Kodama A; Fujii H; Hasegawa A; Kannagi M; Ansari AA; Saito M AIDS Res Hum Retroviruses; 2014 Jun; 30(6):542-52. PubMed ID: 24524420 [TBL] [Abstract][Full Text] [Related]
18. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP. Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429 [TBL] [Abstract][Full Text] [Related]